2 completed. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
Follow Impaired Renal Function: new trials by email Literature Review of Impaired Renal Function trials Research Report on Impaired Renal Function
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of Efficacy and Safety of Ferric Carboxymaltose (FCM) in Patients With Iron Deficiency Anemia and Impaired Renal Function Ferric Carboxymaltose (FCM), Iron Sucrose (Venofer) - Iron Deficiency Anemia, Impaired Renal Function | Phase 3 | Completed | American Regent, Inc. | 2561 | 2009-08-01 | 2018-02-20 |
| CNI-free de Novo Protocol in Patients Undergoing Liver Transplantation With Renal Impairment anti-CD 25 mAb, Sirolimus, MMF - End Stage Liver Disease, Impaired Renal Function | Phase 3 | Completed | University of Regensburg | 27 | 2008-12-01 | 2014-12-16 |
Renal Insufficiency (2) · Anemia, Iron-Deficiency (1) · End Stage Liver Disease (1)
Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Kidney Diseases (2) · Male Urogenital Diseases (2) · Urogenital Diseases (2) · Urologic Diseases (2) · Anemia (1) · Anemia, Hypochromic (1) · Digestive System Diseases (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Hepatic Insufficiency (1) · Iron Deficiencies (1) · Iron Metabolism Disorders (1) · Liver Diseases (1)
Basiliximab (1) · Ferric Oxide, Saccharated (1) · Mycophenolic Acid (1) · Sirolimus (1) · ferric carboxymaltose (1)
American Regent, Inc. (1) · University of Regensburg (1)
Germany (1) · United States (1)
Andreas A Schnitzbauer, MD (1) · Hans J Schlitt, MD (1) · Marcus N Scherer, MD (1)